APREA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.27 USD | -5.72% |
|
-5.72% | +12.13% |
| 14/05 | Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02/05 | Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APREA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -5.72% | -5.72% | +12.13% | +37.24% | - | 30.35M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- APRE Stock
- Charts Aprea Therapeutics, Inc.
- Comparison Chart